| Ireland | | |
Time spent for sleeping (men and women, minutes per day per person) | 491.3 (2005) [26/30countries] | | | Time spent for sleeping (men, minutes per day per person) | 481.9 (2005) [27/30countries] | | | Time spent for sleeping (women, minutes per day per person) | 500.7 (2005) [24/30countries] | | |
|
| Ireland | | |
Time spent for eating and drinking (men and women, minutes per day per person) | 75.4 (2005) [28/30countries] | | | Time spent for eating and drinking (men, minutes per day per person) | 76.1 (2005) [27/30countries] | | | Time spent for eating and drinking (women, minutes per day per person) | 74.7 (2005) [28/30countries] | | |
|
| Ireland | | |
Age-standardized prevalence of tobacco use among persons 15 years and olders (%) | 20.8% (2020) [26/38countries] | | |
|
| Ireland | | |
New HIV infections (per 1000 uninfected population) | 0.08 (2020) [7/19countries] | | | Tuberculosis incidence (per 100,000 population) | 4.8 (2021) [24/38countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.0 (2020) [31/38countries] | | | Reported number of people requiring interventions against NTDs | 1 (2021) [22/34countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 9.7 (2019) [23/38countries] | | | % of those who think that antibiotics can kill bacteria but not viruses | 86.9% (2000) [7/22countries] | | | % of those who think that all man-made chemicals can cause cancer if they eat enough of them | 65.5% (2000) [14/22countries] | | |
|
| Ireland | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 372.8 (2020) [3/38countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 10.6 (2020) [21/38countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 6.0 (2020) [10/38countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 89.9 (2020) [10/38countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 10.7 (2020) [13/38countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 64.4 (2020) [25/38countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 20.0 (2020) [4/38countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.6 (2020) [20/38countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 12.1 (2020) [7/38countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 2.6 (2020) [11/38countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 8.4 (2020) [13/38countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 4.0 (2020) [17/38countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 5.2 (2020) [18/38countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 34.6 (2020) [8/38countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 63.3 (2020) [6/38countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 3.6 (2020) [14/38countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [21/37countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 13.6 (2020) [11/38countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 5.7 (2020) [4/38countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 1.3 (2020) [24/38countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 11.7 (2020) [5/38countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 6.9 (2020) [29/38countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 110.7 (2020) [1/38countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 7.3 (2020) [16/38countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 8.2 (2020) [12/38countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 8.8 (2020) [17/38countries] | | |
|
| Ireland | | |
Suicide, age-standardized (per 100 000 population) | 8.90 (2019) [24/38countries] | | | Suicide - male, age-standardized (per 100 000 population) | 14.32 (2019) [21/38countries] | | | Suicide - female, age-standardized (per 100 000 population) | 3.57 (2019) [24/38countries] | | | Suicide - 15-24 years (per 100,000 population) | 7.55 (2019) [19/38countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 12.16 (2019) [18/38countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 2.78 (2019) [23/38countries] | | | Suicide - 25-34 years (per 100,000 population) | 12.69 (2019) [15/38countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 19.61 (2019) [15/38countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 5.75 (2019) [14/38countries] | | | Suicide - 35-44 years (per 100,000 population) | 12.81 (2019) [19/38countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 21.24 (2019) [16/38countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 4.83 (2019) [21/38countries] | | | Suicide - 45-54 years (per 100,000 population) | 17.29 (2019) [17/38countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 27.70 (2019) [11/38countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 7.01 (2019) [23/38countries] | | | Suicide - 55-64 years (per 100,000 population) | 13.21 (2019) [28/38countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 21.33 (2019) [29/38countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 5.29 (2019) [28/38countries] | | | Suicide - 65-74 years (per 100,000 population) | 11.78 (2019) [25/38countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 19.57 (2019) [24/38countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 4.32 (2019) [28/38countries] | | | Suicide - 75-84 years (per 100,000 population) | 5.30 (2019) [35/38countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 9.43 (2019) [36/38countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 1.73 (2019) [34/38countries] | | | Suicide - 85 years and over (per 100,000 population) | 6.08 (2019) [36/38countries] | | |
|
|